Follow-up to Dan-NICAD I. Clinically relevant prognostic data were assessed with a median follow-up time of three years to evaluate the correlation between CAD- score and prognosis in patients treated by the current standard of care. The long-term prognostic data from the Dan-NICAD I trials was first presented at the ESC Congress in September 2019 by Simon Winther, MD, Ph.D. from Aarhus University Hospital, Denmark, and later published in European Heart Journal – Digital Health.
Dan-NICAD I Prognostic
05
Feb